Search Results - "Borsutzky, Stefan"

The Mycoplasma‐derived lipopeptide MALP‐2 is a potent mucosal adjuvant by Rharbaoui, Faiza, Drabner, Birgit, Borsutzky, Stefan, Winckler, Urte, Morr, Michael, Ensoli, Barbara, Mühlradt, Peter F., Guzmán, Carlos A.

“…The adjuvanticity of MALP‐2, a 2‐kDa synthetic lipopeptide with macrophage‐stimulatory activity, was evaluated in BALB/c mice using β‐galactosidase (β‐gal) as…”
Get full text

Vaccines against typhoid fever by Guzman, Carlos A., Borsutzky, Stefan, Griot-Wenk, Monika, Metcalfe, Ian C., Pearman, Jon, Collioud, Andre, Favre, Didier, Dietrich, Guido

“…Because of high infectivity and significant disease burden, typhoid fever constitutes a major global health problem. Implementation of adequate food handling…”
Get full text

TGF-beta receptor signaling is critical for mucosal IgA responses by Borsutzky, Stefan, Cazac, Balthazar B, Roes, Jürgen, Guzmán, Carlos A

“…TGF-beta receptor (TbetaR) signaling is important for systemic IgA production; however, its contribution to IgA secretion at mucosal sites remained uncertain…”
Get full text

The Mucosal Adjuvant Macrophage-Activating Lipopeptide-2 Directly Stimulates B Lymphocytes via the TLR2 without the Need of Accessory Cells by Borsutzky, Stefan, Kretschmer, Karsten, Becker, Pablo D, Muhlradt, Peter F, Kirschning, Carsten J, Weiss, Siegfried, Guzman, Carlos A

“…The macrophage-activating lipopeptide-2 (MALP-2) is an agonist of the TLR heterodimer 2/6, which exhibits potent activity as mucosal adjuvant, promoting strong…”
Get full text

Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant by Borsutzky, Stefan, Ebensen, Thomas, Link, Claudia, Becker, Pablo Daniel, Fiorelli, Valeria, Cafaro, Aurelio, Ensoli, Barbara, Guzmán, Carlos A.

“…A major goal of HIV-1 vaccine development is the induction of mucosal immune responses able to stop or reduce viral infection directly at the portal of entry…”
Get full text

Efficient mucosal delivery of the HIV‐1 Tat protein using the synthetic lipopeptide MALP‐2 as adjuvant by Borsutzky, Stefan, Fiorelli, Valeria, Ebensen, Thomas, Tripiciano, Antonella, Rharbaoui, Faiza, Scoglio, Arianna, Link, Claudia, Nappi, Filomena, Morr, Michael, Buttó, Stefano, Cafaro, Aurelio, Mühlradt, Peter F., Ensoli, Barbara, Guzmán, Carlos A.

“…A major requirement for HIV/AIDS research is the development of a mucosal vaccine that stimulates humoral and cell‐mediated immune responses at systemic and…”
Get full text

TGF-{beta} Receptor Signaling Is Critical for Mucosal IgA Responses by Borsutzky, Stefan, Cazac, Balthazar B, Roes, Jurgen, Guzman, Carlos A

Get full text